In a recent published report, Kenneth Research has updated the Market report for 3D Cell Culture Market for 2021 till 2030. Report further now discusses; the various strategies to be adopted or being adopted by the business players across the globe at various levels in the value chain. In the view of the global economic slowdown, we further estimated that China, India, Japan and South Korea to recover fastest amongst all the countries in the Asian market. Germany, France, Italy, Spain to take the worst hit and this hit is expected to be regain 25% by the end of 2021- Positive Growth in the economic demand and supply.
U.S. Market recovers fast; In a release on May 4th 2021, the U.S. Bureau and Economic Analysis and U.S. Census Bureau mentions the recovery in the U.S. International trade in March 2021. Exports in the country reached $200 billion, up by $12.4 billion in Feb 2021. Following the continuous incremental trend, imports tallied at $274.5 billion, picked up by $16.4 billion in Feb 2021. However, as COVID19 still haunts the economies across the globe, year-over-year (y-o-y) average exports in the U.S. declined by $7.0 billion from March 2020 till March 2021 whilst imports increased by $20.7 billion during the same time. This definitely shows how the market is trying to recover back and this will have a direct impact on the Healthcare/ICT/Chemical industries, creating a huge demand for 3D Cell Culture Market Products.
Download Sample of This Strategic Report: –https://www.kennethresearch.com/sample-request-10083629
Limitations of the two-dimensional (2D) cell culture models have led to the adoption of the three-dimensional (3D) cell culture in various biological research activities. Compared to the 2D methods, 3D cell culture allows cells to grow in a 3D surrounding that mimics the typical organ microarchitecture. In a 3D environment, cells tend to be exposed to better morphological and physiological changes, contrary to those grown in a 2D environment. Thus, the advantages offered by 3D cell culture in comparison to the 2D ones are key growth drivers for the market. The 3D cell culture market is expected to reach approximately USD 5.33 Bn by 2023, expanding at a compound annual growth rate (CAGR) of 29.2% during the 2018-2023 period.
According to the statistics by the World Bank, the current health expenditure (% of GDP) around the world increased from 9.08% in 2001 to 9.84% in 2018. Additionally, the current health expenditure per capita (current US$) increased from USD 492.99 in 2001 to USD 1110.84 in 2018. Moreover, growing concern for deaths caused due to various diseases and the need for treatment that can lower the crude death rate, which in the year 2019 recorded close to 7% (per 1000 people), are also anticipated to drive the market growth during the forecast period.
Product type segment insights:
The scaffold-based 3D cell culture product segment is dominating the market and will continue to do so during the forecast period. This variant will occupy a market share of 36.6% among all the other product types by 2023. This high share is mainly attributed to the ability of scaffold-based products to impersonate in vivo conditions for the cell culture, thereby driving their adoption among researchers.
“Final Report will add the analysis of the impact of COVID-19 on this industry.”
Download Sample of This Strategic Report: –https://www.kennethresearch.com/sample-request-10083629
Application segment insights:
Depending on applications, the 3D cell culture market is segmented into drug discovery and toxicology, cancer research, and stem cell research/regenerative medicine. The cancer research sub-segment held the largest market share of about 42.8% in the year 2017. This is mainly attributed to the advantages offered by 3D cell culture over its 2D counterpart, growing number of cancer related researches, and funding initiatives across the globe. 3D cultures of cancer cells can generate new drug candidates for a researcher before moving to expensive and time-consuming animal models. 3D cell culture can speed discovery and save money involved in developing cancer models for preclinical screening and testing, as well as for the research and development (R&D) of new therapies.
End users segment insights:
3D cell culture is used across multiple end user segments, such as biotechnology and pharmaceutical companies, contract research laboratories, and academic institutes. Among these, the biotechnology and pharmaceutical companies dominated the market with a revenue of USD 0.77 Bn and 67% market share in 2017. This is primarily due to rising adoption of 3D cell culture as a new tool in early drug discovery, as well as potential treatment of diseases. Furthermore, rising need to continuously improve the productivity of pharmaceutical R&D is further accelerating implementation of 3D cell cultures in the early discovery of drugs.
Regional insights:
Based on regions, North America held the largest market share of about 41.8% of the global 3D cell culture market in the year 2017. This is because of a large number of ongoing research activities in this region, coupled with the availability of sufficient funding for research institutes to opt for relatively costlier technique such as 3D cell culture methods. The countries of the Asia-Pacific region will grow at the highest CAGR in the forecast period owing to rising number of contract research activities, growing focus of pharmaceutical and biotechnological companies on this region for their R&D activities, and increasing awareness among researchers about the benefits of 3D cell culture over 2D methods.
Companies covered:
1. Thermo Fisher Scientific
2. Corning Inc.
3. Lonza Group
4. Merck & Co.
5. InSphero AG
6. Hamilton
7. Kuraray
8. Emulate
9. Mimetas
10. Global Cell Solutions Inc.
Customizations available
With the given market data, Kenneth Research offers customizations according to specific needs. Write to us at sales@kennethresearch.com, or connect with us here.
The report further discusses the market opportunity, compound annual growth rate (CAGR) growth rate, competition, new technology innovations, market players analysis, government guidelines, export and import (EXIM) analysis, historical revenues, future forecasts etc. in the following regions and/or countries:
- North America (U.S. & Canada) Market size, Y-O-Y growth, Market Players Analysis & Opportunity Outlook
- Latin America (Brazil, Mexico, Argentina, Rest of Latin America) Market size, Y-O-Y growth & Market Players Analysis & Opportunity Outlook
- Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC, Poland, Turkey, Russia, Rest of Europe) Market size, Y-O-Y growth Market Players Analys & Opportunity Outlook
- Asia-Pacific (China, India, Japan, South Korea, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia-Pacific) Market size, Y-O-Y growth & Market Players Analysis & Opportunity Outlook
- Middle East and Africa (Israel, GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, Rest of Middle East and Africa) Market size, Y-O-Y growth Market Players Analysis & Opportunity Outlook
For More Reports:Stem Cell Research in India 2021 Market
Nutraceuticals Market
CT Scanner Market
OTC Drug Market
MRI Market
Ventilator Market
Neonatal Ventilator Market
Oncology Pharmaceuticals Market
Medical Imaging Market
Active Pharmaceutical Ingredients Market
About Kenneth Research:
Rated as one of the best multi-client reselling agencies, Kenneth Research provides a single platform for insights on numerous industries for investors and companies who are willing to expand their business. The platform caters to industries that include Healthcare and Pharmaceuticals, Chemicals, ICT and Telecom, Energy and Power, Automotive and Transportation, and several others, and offers the best strategic business consultancy services at a global level.
Contact Us
Name: Kenneth research
Email: sales@kennethresearch.com
Phone: +1 313 462 0609
